Manufacturing Networking Pharmaceutical products 
European Pharmaceutical Review
DECEMBER 5, 2024
Through a new agreement, Eli Lilly and Company and contract development and manufacturing organisation (CDMO) Cambrex will enable external biotech collaborators to accelerate their product development. Collaborators can also access additional support will be provided by Cambrex’s network.
eMediWrite
OCTOBER 3, 2022
Understanding a product’s life cycle can assist a company in determining its position in the market relative to rivals and the success or failure of the product. Complex collaborative outsourcing networks management. But certainly, there are some challenges in the process. Technology transfer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 22, 2022
The use of vibrational spectroscopy, including raman mapping, to study pharmaceutical products has been widely applied across the industry for several decades. These techniques can be utilised to understand polymorphs, intra- and inter-molecular interactions and solid form changes within pharmaceutical products.
European Pharmaceutical Review
JULY 21, 2023
Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. Globalisation and supply chain complexity are a factor.
European Pharmaceutical Review
SEPTEMBER 7, 2022
Dissolution is critical to the bioavailability of a pharmaceutical product – a critical quality attribute – and so is closely monitored using in vitro methods and modelling. Raman chemical imaging has been used to elucidate the structure of formulations and how these change during drug release.
Pharmaceutical Representative Training
MARCH 17, 2025
One of the most difficult parts of introducing a pharmaceutical product is the regulatory environment. Social network findings at the community level are or can be used for medication research and clinical trials. Nowadays, a lot of healthcare professionals prefer digital updates that are timely and pertinent.
European Pharmaceutical Review
JANUARY 16, 2023
Clearly the number one challenge in 2022, as mandated by the EU GMP Guidelines for the Manufacture of Sterile Medicinal Products Annex 1 1 , is the development of a Contamination Control Strategy (CCS),” Tony Cundell noted. He questioned how regulators will enforce revisions to Good Manufacturing Practice (GMP) regulations.
Expert insights. Personalized for you.
52 
Let's personalize your content